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Summary:
With multiple possible mediators on the causal pathway from a treatment to an outcome, we consider the problem
of decomposing the effects along multiple possible causal path(s) through each distinct mediator. Under Pearl’s path-
specific effects framework (Pearl, 2001; Avin et al., 2005), such fine-grained decompositions necessitate stringent
assumptions, such as correctly specifying the causal structure among the mediators, and no unobserved confounding
among the mediators. In contrast, interventional direct and indirect effects for multiple mediators (Vansteelandt and
Daniel, 2017) can be identified under much weaker conditions, while providing scientifically relevant causal inter-
pretations. Nonetheless, current estimation approaches require (correctly) specifying a model for the joint mediator
distribution, which can be difficult when there is a high-dimensional set of possibly continuous and non-continuous
mediators. In this article, we avoid the need to model this distribution, by developing a definition of interventional
effects previously suggested by VanderWeele and Tchetgen Tchetgen (2017) for longitudinal mediation. We propose
a novel estimation strategy that uses non-parametric estimates of the (counterfactual) mediator distributions. Non-
continuous outcomes can be accommodated using non-linear outcome models. Estimation proceeds via Monte Carlo
integration. The procedure is illustrated using publicly available genomic data (Huang and Pan, 2016) to assess the
causal effect of a microRNA expression on the three-month mortality of brain cancer patients that is potentially
mediated by expression values of multiple genes.
Key words: Collapsibility; Direct and indirect effects; Effect decomposition; Marginal and conditional effects;
Multiple mediation analysis; Path analysis
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1. Introduction
Mediation analysis is commonly used to study the effect of a treatment or exposure (A) on
an outcome (Y ) that may be transmitted through intermediate variable(s) on the causal
pathway from A to Y . Counterfactual-based definitions of natural direct and indirect effects
(Robins and Greenland, 1992; Pearl, 2001) permit decomposing the total effect of a treatment
on an outcome into a direct and an indirect effect for a single mediator, without relying
on any specific statistical models for the mediator and outcome. However, multiple possible
mediators often exist in substantive research. For example, different mediators may be posited
in trying to understand the different causal pathways from A to Y , or confounders of the
mediator-outcome relation for a mediator of interest are themselves affected by treatment
and thus perceived as competing mediators, or interventions may be designed to affect
outcome by simultaneously changing different mediators on the causal pathway from A to
Y . Extensions of natural effects for a single mediator to the multiple mediator setting are
therefore complicated by the complex (possibly unknown) confounding patterns among the
different mediators. In particular, when one mediator exerts a causal effect on another, so
that the former is a confounder of the mediator-outcome relation for the latter (henceforth
termed post-treatment confounding), the assumptions needed to (non-parametrically) identify
the natural or separate path-specific effects through each mediator are violated (Avin et al.,
2005). Consider the following example in Figure 1. The natural indirect effect via M3 alone
cannot be identified because M1 and M2 are post-treatment confounders of the M3 − Y
relation. The path-specific indirect effect along the assumed path A → M1 → M2 → Y
cannot be identified because U is an unobserved confounder of M1 and M2.
[Figure 1 about here.]
Current methods for assessing natural effects with multiple mediators are restricted to
situations where either the mediators can be causally ordered so that (combinations of) path-
2specific effects can be identified in the presence of post-treatment confounding (VanderWeele
and Vansteelandt, 2014; Daniel et al., 2015; Steen et al., 2017; Albert et al., 2019), or the
mediators do not exert causal effects on each other, and are independent given treatment
and covariates (Lange et al., 2013; Taguri et al., 2018). Hence a limitation, shared by all
the above approaches, is that they are predicated on (correct) a priori assumptions about
the detailed causal relations between the mediators. These restrictions impede applications
in most realistic settings, when the causal structure among the mediators is unknown or
cannot be (correctly) specified based on sound scientific knowledge or empirical evidence, or
the mediators are manifestations of a latent process or variable, and thus correlated.
In contrast, interventional direct and indirect effects, first introduced by Didelez et al.
(2006) and VanderWeele et al. (2014) for a single mediator, can be identified under much
weaker assumptions than natural or path-specific effects, especially when there is post-
treatment confounding of the mediator(s)-outcome relation(s). Interventional effects consider
population-level (stochastic) interventions that set the value of the mediator to a random
draw from its (counterfactual) distribution; whereas natural effects are defined in terms of
individual-level (deterministic) interventions on the mediator, which can lack scientific and
practical meaning when the treatment cannot be manipulated at the individual level (Van-
derWeele, 2013). Vansteelandt and Daniel (2017) extended the definitions to the multiple
mediator setting so that the total effect of a treatment on an outcome can be decomposed into
a direct effect and a joint indirect effect via the mediators. They further decomposed the joint
indirect effect into separate indirect effects via each distinct mediator, and an indirect effect
via the mediators’ mutual dependence. Interventional indirect effects are defined in terms
of the underlying (possibly unknown) causal effects among the mediators. They therefore
possess valid interpretations by construction, and can be identified without prior (correct)
specification of the mediators’ causal structure, and even when mediators share hidden
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common causes. Recent work discussing interventional (in)direct effects include Moreno-
Betancur and Carlin (2018), Lok (2019), and Quynh Nguyen et al. (2019), among others,
for a single mediator; VanderWeele and Tchetgen Tchetgen (2017) for a single longitudinal
mediator; Lin and VanderWeele (2017) for multiple mediators with a known causal ordering;
and Loh et al. (2019) for comparisons with prevalent “product-of-coefficients” methods
(MacKinnon, 2000; Preacher and Hayes, 2008) assuming linear models for all variables.
In this article, we generalize the interventional effects framework for multiple mediators
to high-dimensional mediators. A key complication when estimating current definitions
of the interventional effects is the need to correctly specify a (parametric) model for the
joint distribution for all mediators conditional on treatment and all observed confounders.
However, VanderWeele and Tchetgen Tchetgen (2017) suggested the possibility of inter-
ventional effects defined using (counterfactual) mediator distributions that depend only on
treatment, and are unconditional on the baseline confounders of the mediator(s)-outcome
relation(s). Such definitions avoid specifying (marginal structural) models for the mediators
in terms of the baseline confounders, and can thus be particularly advantageous when
there is a high-dimensional set of (non-)continuous mediators. All current high-dimensional
mediation methods for assessing indirect effects through each distinct mediator are restricted
to continuous mediators, with almost all additionally considering only continuous outcomes,
so that the product-of-coefficients method under assumed linear models for (transformations
of the) mediators and outcomes can be employed; see e.g., Chakrabortty et al. (2018), Huang
and Pan (2016), Zhang et al. (2016), Zhao and Luo (2016), Zhao et al. (2019), Derkach et al.
(2020), and Zhao et al. (2020) among many others. While most methods allow for either
correlated errors in the joint mediator model (thus allowing for certain forms of hidden
confounding among the mediators), or mediators to influence one another, only Zhao and
Luo (2016) and Zhao et al. (2019) allow for both within the same mediation model. In most re-
4alistic and important settings, high-dimensional mediators that are closely linked either have
complex but unknown causal relations, or share unmeasured common causes, or both. Even
in the single mediator setting, indirect effects using the traditional product-of-coefficients
method may not correspond to those derived using the causal mediation framework, due to
misspecification of non-linear models for non-continuous mediator and outcome (MacKinnon
et al., 2018). With the increasing demand for high-dimensional mediation methods in biology,
medical and public health research, our proposal is, to the best of our knowledge, the first
to allow for both continuous and non-continuous mediators to simultaneously exist on the
causal pathway between treatment and outcome, where they can concurrently causally affect
one another, and share hidden common causes.
In this article, we therefore build on the suggestion by VanderWeele and Tchetgen Tchetgen
(2017) for a single (longitudinal) mediator to develop interventional direct and indirect effects
for high-dimensional mediators. Our proposed definitions of interventional indirect effects
differ from existing definitions by Vansteelandt and Daniel (2017), Lin and VanderWeele
(2017), and Loh et al. (2019) in two respects. The first is that the decomposition of the joint
indirect effect into separate indirect effects via each mediator is invariant to the presumed
(possibly arbitrary) ordering of the mediator indices. Existing definitions assume different
hypothetical treatment levels for different subsets of the mediators, thus allowing the possi-
bility of different decompositions (depending on the mediator indices). The second and more
pertinent difference is that the interventional indirect effects developed in this article rely
on (counterfactual) mediator distributions that depend only on treatment, whereas existing
definitions depend on treatment and all baseline covariates. In high-dimensional mediation
settings, specifying a (correct) model for the joint distribution for all mediators that is
congenial with models for the marginal distribution for each mediator, all of which are con-
ditional on the covariates, can be difficult. The definitions proposed in this article therefore
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permit a novel estimation strategy that requires specifying only a (marginal structural) mean
model for the outcome, and no models for the mediators. The mediators and outcome can be
continuous or noncontinuous, with non-continuous outcomes accommodated using non-linear
outcome models. Non-parametric estimates of the (counterfactual) mediator distributions
under each treatment level are used. Estimation proceeds via Monte Carlo integration.
The remainder of this article is as follows. In Section 2 notation is introduced, the in-
terventional direct and indirect effects are defined, and the identification assumptions are
stated. In Section 3 the novel estimation strategy that requires no models for the mediators,
and only a mean model for the outcome, is proposed. For pedagogic purposes, we will
focus on randomized studies with fewer mediators than observations in the theoretical
development of our proposed procedure. Extensions to high-dimensional mediators, and
observational studies when treatment is not randomly assigned, are then described. In
Section 4 the proposed estimation procedures are assessed via extensive simulation studies.
In Section 5 the estimation strategy is illustrated using publicly-available data from a
previous high-dimensional mediation analysis (Huang and Pan, 2016) that investigated the
causal effect of a microRNA expression (miR-223) on a dichotomous three-month survival
status among patients suffering from an aggressive form of brain cancer, that is potentially
mediated by expression values of different genes. In Section 6 we demonstrate that in
most common settings, the proposed estimation procedure simplifies current estimation
approaches (Vansteelandt and Daniel, 2017; Loh et al., 2019), by eliminating the need to
specify a model for the joint distribution of the mediators. A brief discussion is provided in
Section 7.
2. Definition and identification of interventional (in)direct effects
Consider the setting with an exposure or a treatment A, multiple possible mediators M1, . . . ,Mp,
and an outcome Y . In this article, we adopt the perspective that all post-treatment con-
6founders of a mediator-outcome relation for a mediator in question are themselves competing
mediators, and therefore included in the set of possible mediators. Here and throughout
subscripts in the notation for the mediators are merely used to arbitrarily index the different
mediators, and not to indicate any assumed causal (or temporal) ordering of the mediators;
e.g., M1 need not precede M2 causally (or temporally). Let Yam1···mp denote the potential
outcome for Y if, possibly counter to fact, A is set to a, when each mediator Ms is set
to the value ms, s = 1, . . . , p. Let Msa(s) denote the potential outcome for Ms if, possi-
bly counter to fact, A is set to a(s). Let Ya(0){M˜
1a(1)
···M˜
pa(1)
} denote the potential outcome
for Y under treatment A = a(0), when the mediator values are set to a random draw
from the joint (counterfactual) distribution under (hypothetical) treatment A = a(1), i.e.,
{M˜1a(1) · · · M˜pa(1)} ∼ F (M1a(1) , . . . ,Mpa(1)), where F (X) denotes a cumulative distribution
function for X. Potential outcomes where the mediators are set to random draws from the
joint counterfactual distribution are henceforth denoted by (curly) brackets in the subscripts.
Let Ya(0)M˜
1a(1)
···M˜
pa(p)
denote the potential outcome under treatment A = a(0), when the value
of each mediator is set to a random draw from the marginal (counterfactual) distribution
that does not depend on any other mediator, i.e., M˜sa(s) ∼ F (Msa(s)), s = 1, . . . , p. Let
L denote all observed baseline (i.e., unaffected by treatment) covariates that may affect
any of (A,M1, . . . ,Mp, Y ). Here and throughout, the joint and all marginal distributions
for the (counterfactual) mediators are unconditional on L. The average potential outcomes
(hereafter termed “estimands”) are respectively defined as:
E
(
Ya(0){M˜
1a(1)
···M˜
pa(1)
}
)
=
∫
E(Ya(0)m1···mp) dFM1a(1) ,··· ,Mpa(1) (m1, · · · ,mp), and (1)
E
(
Ya(0)M˜
1a(1)
···M˜
pa(p)
)
=
∫
E(Ya(0)m1···mp) dFM1a(1) (m1) · · · dFMpa(p) (mp). (2)
2.1 Interventional (in)direct effects for multiple mediators
The interventional effects comparing estimands (1) and (2) under different hypothetical
treatment levels for a binary treatment A are defined as follows. Let g denote a user-specified
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link function, such as the log link g(x) = log(x), or the “logit” link g(x) = log{x/(1 − x)}.
Define the total effect as:
g
{
E
(
Y1{M˜11···M˜p1}
)}
− g
{
E
(
Y0{M˜10···M˜p0}
)}
,
which can be decomposed into the direct effect, defined as:
g
{
E
(
Y1{M˜11···M˜p1}
)}
− g
{
E
(
Y0{M˜11···M˜p1}
)}
, (3)
and the (joint) indirect effect, defined as:
g
{
E
(
Y0{M˜11···M˜p1}
)}
− g
{
E
(
Y0{M˜10···M˜p0}
)}
. (4)
The indirect effect via each mediator Ms, s = 1, . . . , p, is defined as:
g
{
E
(
Y0M˜10···M˜s−1,0 M˜s1 M˜s+1,0···M˜p0
)}
− g
{
E
(
Y0M˜10···M˜p0
)}
. (5)
Changing only the marginal counterfactual distribution of Ms from treatment to control
implies an “overall” effect of treatment on Ms that is unconditional on any other mediators.
This effect therefore marginalizes over all (underlying) causal effects along (unknown) paths
from treatment to the mediator in question that may intersect other causally antecedent me-
diators. Hence the interventional indirect effect through a mediator can be readily interpreted
as the combined causal effect along all (underlying) paths from treatment to the mediator in
question, then directly to the outcome. Continuing the example shown in Figure 1, the
indirect effect through M3 is the combined effect along the paths A → M3 → Y and
A → M1 → M3 → Y . Further interpretations are deferred to the simulation studies in
Section 4 and the illustration in Section 5.
Note that in the first term of (5), only the mediator in question Ms is drawn from its
distribution under treatment a(s) = 1; all other mediators are drawn from their distributions
under control, i.e., a(k) = 0 for k = 1, . . . , p, k 6= s. This definition of the indirect effect
(5) is especially amenable to settings with high-dimensional mediators because it does not
require fixing the hypothetical treatments for the other mediators at different levels, and
is hence invariant to the chosen (possibly arbitrary) ordering of the mediator indices. In
8contrast, existing definitions (Vansteelandt and Daniel, 2017; Loh et al., 2019) set a(k) = 1
for k = 1, . . . , s−1, and a(k) = 0 for k = s+1, . . . , p, so that different definitions are possible
depending on the mediator indices, although the conceptual interpretations remain the same.
Lastly, the difference between the joint indirect effect (4) and the sum of the separate
indirect effects (5) for all mediators can be further partitioned into:
[
g
{
E
(
Y0{M˜11···M˜p1}
)}
− g
{
E
(
Y0M˜11···M˜p1
)}]
−
[
g
{
E
(
Y0{M˜10···M˜p0}
)}
− g
{
E
(
Y0M˜10···M˜p0
)}]
, (6)
and
[
g
{
E
(
Y0M˜11···M˜p1
)}
− g
{
E
(
Y0M˜10···M˜p0
)}]
−
p∑
s=1
[
g
{
E
(
Y0M˜10···M˜s−1,0 M˜s1 M˜s+1,0···M˜p0
)}
− g
{
E
(
Y0M˜10···M˜p0
)}]
. (7)
Following Vansteelandt and Daniel (2017), we refer to (6) as the indirect effect via the
mediators’ mutual dependence. This indirect effect describes how treatment affects the rela-
tionships between the mediators, which subsequently affects the outcome, and thus cannot be
attributed to any single mediator. We term the indirect effect in (7) as the “remainder” effect
after removing the indirect effect via the mutual dependence (6) from the difference between
the joint indirect effect (4) and the sum of the separate indirect effects (5). Interpretations
and closed-form expressions for the indirect effects (6) and (7), under the setting with two
mediators and (non-)linear models for the mediators (and outcome), are provided in the Web
Appendix. For example, when the mean model for the outcome is linear and the mediators
are normally distributed, the indirect effect via the mediators’ mutual dependence (6) is
non-zero if and only if the covariance of the mediators is affected by treatment and the
mediator-mediator interaction effect on the outcome is non-zero. When the mean model for
the outcome is log-linear and the mediators are normally distributed, this indirect effect is
non-zero if and only if the covariance of the mediators is affected by treatment and the main
effects of the mediators on the outcome are both non-zero.
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2.2 Assumptions for identification
Identification of the interventional effects requires the following assumptions, where “⊥”
denotes conditional independence:
Yam1···mp ⊥ A|L ∀ a,m1, . . . ,mp; (8)
Yam1···mp ⊥ {M1 · · ·Mp}|(A = a, L) ∀ a,m1, . . . ,mp; (9)
{M1a · · ·Mpa} ⊥ A|L ∀ a. (10)
Assumptions (8) and (10) state that the effect of treatment A on outcome Y , and the
effects of treatment A on all mediators, are unconfounded conditional on L. Assumption (9)
states that there is sufficient information observed in L so that the association between
any of the mediators (M1, . . . ,Mp) and outcome Y is unconfounded within levels of the
covariates L. Because this assumption is not empirically testable, all baseline measurements
of the mediators and the outcome (prior to treatment being received) should be adjusted
for in practice, even when treatment is randomly assigned. We refer readers to Smith and
VanderWeele (2019) for implications when this assumption is violated, and recommended
sensitivity analyses.
3. Estimation of interventional (in)direct effects
In this section we develop a novel estimation strategy that requires only an outcome model,
and no models for the mediators. The strategy exploits the proposed definitions of the
interventional effects using (counterfactual) mediator distributions that are unconditional
on any covariates. For pedagogic purposes, we will first assume that there are sufficient
observations for an unpenalized outcome model, conditional on treatment, all mediators,
and covariates, to be fitted to the observed data. We will further assume that treatment
is randomly assigned so that both independence assumptions (8) and (10) are satisfied
unconditionally on L. Extensions to high-dimensional mediators, and observational studies
with non-randomly assigned treatments, are presented in later sections.
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3.1 Randomly assigned treatment with an unpenalized outcome model
Estimators of the proposed interventional (in)direct effects are obtained as follows:
A0. Fit an outcome model, conditional on treatment, mediators, and covariates, to the observed
data, e.g., E(Y |A,M1, . . . ,Mp, L). The outcome model can be expressed as a function of its in-
puts, e.g., E(Y |A = a,M1 = m1, . . . ,Mp = mp, L) = h(a,m1, . . . ,mp, L), where h(·) is a user-
specified function. The observed values of the covariates L for each individual are assumed
to be fixed and invariant to different values of the treatment a and counterfactual mediator
values (denoted by m1, . . . ,mp). Denote the estimated function by hˆ(a,m1, . . . ,mp, L).
A1. Construct the duplicated data for each individual as shown in Table 1. The hypothetical
treatment levels a(0) and a(1) are chosen so that the interventional direct effect (3) is the dif-
ference between the (transformed) estimands in the last and penultimate rows, and the joint
indirect effect (4) is the difference between the (transformed) estimands in the penultimate
and first rows.
[Table 1 about here.]
A2. For each row of Table 1, randomly draw the counterfactual mediator values {M˜1a(1) · · · M˜pa(1)}
jointly from the observed treatment group A = a(1). Because treatment is randomly assigned,
there are no confounders of the treatment and the (counterfactual) mediators, and assump-
tion (10) is satisfied unconditionally on L. Randomly select an individual whose observed
treatment is A = a(1), then set the counterfactual mediators {M˜1a(1) · · · M˜pa(1)} to the selected
individual’s observed values {M1 · · ·Mp}.
A3. Impute the expected potential outcomes as predictions hˆ(a(0), M˜1a(1) , . . . , M˜pa(1) , L) from
the fitted outcome model in step A0.
A4. Repeat steps A2 and A3 to account for the variability in the (counterfactual) mediator val-
ues, thereby obtaining the (Monte Carlo averaged) imputed potential outcomes E
(
Ya(0){M˜
1a(1)
···M˜
pa(1)
}|L
)
for each individual.
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A5. For each unique value of {a(0), a(1)} in Table 1, calculate the average imputed potential
outcome E
(
Ya(0){M˜
1a(1)
···M˜
pa(1)
}
)
across all individuals in the observed sample, which in doing
so, averages over the empirical distribution of the covariates L. The estimators of the direct
effect (3) and joint indirect effect (4) are obtained by plugging in the sample averages for
the unknown (population) quantities.
Next, we estimate the separate indirect effects via each mediator. In general, the potential
outcome Ya(0)M˜
1a(1)
···M˜
pa(p)
is unobservable, even when the hypothetical treatments all equal
the observed treatment (i.e., a(0) = a(1) = . . . = a(p) = A). This is because each counter-
factual mediator M˜sa(s) , even under the observed treatment a
(s) = A, has to be drawn from
its marginal (counterfactual) distribution that does not depend on any other mediators by
definition. In contrast, the observed values {M1 · · ·Mp} are jointly distributed according to
some (unknown) distribution for all the mediators. Estimating the indirect effects via each
mediator therefore requires randomly sampling (counterfactual) mediator values from their
marginal distributions, and proceeds as follows:
B1. Construct the duplicated data for each individual as shown in Table 2. Set all hypothetical
treatments in the first row to 0; i.e., a(0) = a(1) = . . . = a(p) = 0. For s = 1, . . . , p, set the
hypothetical treatments in row s+ 1 to those in the first term of the interventional indirect
effect via mediator Ms as defined in (5); i.e., a
(s) = 1 in row s + 1, and 0 otherwise. The
hypothetical treatment levels are chosen so that the interventional indirect effect via each
mediator Ms corresponds to the difference between the (transformed) estimands in rows s+1
and 1. In the last row, set a(0) = 0 and a(1) = . . . = a(p) = 1. The interventional indirect effect
via the mediators’ mutual dependence (6) is thus the difference between (i) the difference in
(transformed) estimands in the penultimate and first rows of Table 1, and (ii) the difference
in (transformed) estimands in the last and first rows of Table 2.
[Table 2 about here.]
12
B2. In each row of Table 2, for column s = 1, . . . , p, randomly sample the counterfactual
mediator M˜sa(s) , unconditionally on the other mediators, from the observed treatment group
A = a(s). This can be carried out by randomly selecting an individual whose observed treat-
ment is A = a(s), then setting the counterfactual mediator M˜sa(s) to the selected individual’s
observed value Ms. Because the randomly assigned treatment is jointly independent of all
the (counterfactual) mediators when assumption (10) holds, it implies that the treatment is
marginally independent of each (counterfactual) mediator, unconditionally on L.
B3. Impute the expected potential outcomes as a prediction hˆ(0, M˜1a(1) , . . . , M˜pa(p) , L) from the
fitted outcome model in step A0.
B4. Repeat steps B2 and B3 to account for the variability in the (counterfactual) mediator val-
ues, thereby obtaining the (Monte Carlo averaged) imputed potential outcomes E
(
Ya(0)M˜
1a(1)
···M˜
pa(1)
|L
)
for each individual.
B5. For each unique value of {a(0), a(1), . . . , a(p)} in Table 2, calculate the average imputed
potential outcome E
(
Ya(0)M˜
1a(1)
···M˜
pa(p)
)
across all individuals in the observed sample. The
estimators of the interventional indirect effect via each mediator Ms (5) are obtained by
plugging in the sample averages for the unknown (population) quantities. The estimator of
the indirect effect via the mediators’ mutual dependence (6) is similarly obtained using the
sample averages in the second and first rows of Table 1, and the last and first rows of Table 2.
Unbiased estimation of the interventional effects therefore depends on correctly specifying
an outcome model conditional on treatment, mediators, and covariates that is unbiased for
the marginal structural mean model; i.e., hˆ(a,m1, . . . ,mp, L) converges in probability to
E
(
Yam1···mp|L
)
. The consistency of the estimator under the identifying assumptions (8)–(10)
is shown in Web Appendix ??. Standard errors can be estimated using a non-parametric
percentile bootstrap procedure (Efron and Tibshirani, 1994) that randomly resamples ob-
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servations with replacement, then repeating steps A0 – A5 and B1 – B5 for each bootstrap
sample.
3.2 High-dimensional mediators
In this section, we consider high-dimensional mediation settings with fewer observations
than mediators (and covariates). Separate mediation analyses can lead to biased estimates
of indirect effects because merely omitted mediators can act as unobserved (post-treatment)
confounders of the mediator(s) in question and the outcome, thus violating assumption
(9). Recall the example in Figure 1, where M1 and M2 are confounders of the M3 − Y
relation. A single mediation analysis for M3 that ignores either M1 or M2, or both, will
yield biased estimates of the indirect effect via M3. In this section, we propose a strategy
to estimate the separate indirect effects via each mediator, by focusing on each distinct
mediator Ms, s = 1, . . . , p, in turn. For the mediator Ms in question, possible confounding of
the mediator-outcome relation (by other mediators or possibly high-dimensional covariates)
is carefully adjusted for to ensure unbiased estimation of the interventional indirect effect.
3.2.1 Outcome model. First, fit a penalized regression model for the outcome to the
observed data. Here and throughout, we will consider an elastic net penalty (Zou and Hastie,
2005), which is a compromise between the ridge regression penalty and the lasso penalty. The
elastic net penalty is especially useful when there are many correlated predictor variables, and
has been applied to different gene expression datasets with highly correlated genes (Friedman
et al., 2010). Because evaluating the indirect effect via Ms requires jointly assessing the
Ms−Y and A−Ms relations, (prematurely) shrinking the coefficient of Ms to zero can lead
to biased inference. The coefficients for A and Ms should therefore be unpenalized, e.g., by
setting their penalty factors to zero, to retain both A and Ms in the outcome model. Denote
the subset of the remaining mediators and covariates with non-zero (penalized) coefficients
by Ms(Y ), where the subscript emphasizes the focus on mediator Ms.
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3.2.2 Mediator model. Next, to increase the chances of detecting confounders of the Ms−
Y relation, fit a penalized regression model (using an elastic net penalty) for Ms conditional
on all other mediators, treatment, and covariates to the observed data. Denote the subset of
the predictors with non-zero (penalized) coefficients by Ms(M).
3.2.3 Indirect effect via each distinct mediator. Denote the union of the selected pre-
dictors (with non-zero coefficients) in either the penalized outcome model or the penalized
mediator model by Ms =Ms(Y )
⋃Ms(M). The selected mediators and covariates in Ms
are thus possible confounders of the Ms−Y relation, and can be included in a new outcome
model. Denote this outcome model by h(A,Ms,Ms), where the dependence on only the
selected mediators (and covariates) in Ms is implied. To estimate the indirect effect via
Ms, carry out steps B1 – B5 using only rows s + 1 and 1 of Table 2. Predictions from the
(unpenalized) outcome model h(A,Ms,Ms) fitted to the observed data are used to impute
potential outcomes in step B4.
3.2.4 Remarks. Separately selecting predictors of the outcome in Ms(Y ) and predictors
of the mediator inMs(M) can increase the chances of selecting (observed) confounders of the
Ms−Y relation. Continuing the example in Figure 1, suppose that M2 is omitted fromM3(Y )
due to sampling variability, but selected inM3(M). Then M2 ∈M3 would still be adjusted
for in the outcome model h(A,M3,M3). The use of separate outcome and mediator models
is inspired by double selection principles (Belloni et al., 2014), where in settings without
mediators, the (partial) associations between the outcome and the covariates, and between
the treatment and the covariates, are evaluated. We acknowledge that specifying mediator
models may appear contradictory to the key feature of our proposal that avoids modeling the
relations between the mediators. But we emphasize that the (penalized) regression model for
each mediator in question is used merely to identify possible confounders of the mediator-
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outcome relation, by essentially viewing the other mediators as possible confounders. These
models do not assume (or empirically imply) any causal structure among the mediators.
3.3 Observational studies with non-randomly assigned treatments
When treatment is not randomly assigned, the counterfactual mediator values used to
construct the duplicated data in the estimation procedure cannot be sampled by merely
selecting mediator values at random within each observed treatment group. The observed
baseline confounders L of the treatment-mediator(s) and treatment-outcome relations have
to be adjusted for toward ensuring that the identifying assumptions (8) and (10) hold. For
example, the counterfactual density for mediator Ms when setting A to a is:
f(Msa) =
∫
f(Ms|A = a, L = l)f(L = l)f(L = l|A = a)−1 dFL|A=a(l)
= Pr(A = a)
∫
f(Ms|A = a, L = l) Pr(A = a|L = l)−1 dFL|A=a(l), a = 0, 1.
The above result motivates a modified estimation procedure for non-randomly assigned
treatments, by sampling the (observed) mediator values with probability proportional to
the inverse of the conditional probability of receiving the observed treatment given the
confounders. For example, suppose that a(s) = 0. Consider an individual in the treatment
group A = 0 with covariate values L = l and observed mediator value Ms. The sampling
probability of this particular individual’s value of Ms is Pr(A = 0|L = l)−1/{
∑
i Pr(A =
0|L = li)−11 (Ai = 0)}, where the sum in the denominator is over all individuals i (as indexed
by the i superscripts without brackets) with covariate values L = li in the (same) treatment
group Ai = 0. The (counterfactual) mediator value(s) can be readily sampled by randomly
selecting an individual from the treatment group A = a(s) according to the aforementioned
sampling probabilities, then setting the counterfactual mediator to the selected individual’s
observed mediator value(s). In practice, the probabilities of the observed treatments Pr(A =
a|L), a = 0, 1, may be estimated using predictions from a (saturated) logistic regression
model fitted to the observed data, with the treatment as the dependent variable, and main
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effects (and when feasible, higher order and interaction effects) for the covariates as the
predictors.
4. Simulation studies
Two simulation studies were conducted to empirically assess the operating characteristics of
the proposed estimation strategy in finite samples across different settings. Details of the pro-
cedures and results of these simulation studies are deferred to Web Appendix ??. To provide
an overview, in study 1, we considered a setting with two (continuous) mediators where one
was affected by the other. The estimators of the interventional effects proposed in this article
were compared with existing estimators of natural effects (Steen et al., 2017) that required
stricter identification assumptions. Settings where the causal ordering of the mediators was
either correctly or incorrectly assumed, and unobserved confounding of the mediators was
either present or absent, were considered. In study 2, a setting with high-dimensional (non-
continuous) mediators was considered for assessing the indirect effect estimators proposed
in Section 3.2. The outcome was binary in both studies.
The results of the simulation studies showed that estimators of the existing natural indirect
effects were unbiased only when the identifying assumptions were met; i.e., the mediators’
causal ordering was correctly assumed, and there was no unobserved confounding of the
mediators. As expected, when at least one of the assumptions was violated, estimates were
biased even at large sample sizes. In contrast, estimators of the interventional effects proposed
in this article were unbiased under all the considered settings. The proposed estimation
strategy for high-dimensional mediators was able to detect the mediators through which the
indirect effects were transmitted with high probability empirically. The estimated indirect
effects were empirically biased at smaller sample sizes, but the biases tended to zero as the
sample sizes increased.
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5. Illustration with an example dataset
We illustrated the proposed estimation strategy using publicly available data from a previous
high-dimensional mediation analysis by Huang and Pan (2016). Huang and Pan assessed
whether the causal effect of the microRNA miR-223 expression (the treatment of interest)
on mortality within three months due to glioblastoma multiforme (GBM), a malignant brain
tumor, was mediated by expression values of different genes in the tumor genome. Expression
values for 1220 genes (with no missing data) from 490 patients suffering from GBM were
included in the online supplemental materials of Huang and Pan (2016). Interventional effects
are suitable for such high-dimensional mediator settings because the mediators’ internal
causal structure, such as gene regulation networks or protein signaling networks, are often
unknown in practice. For the purposes of illustrating the proposed estimation strategy, we
made the following simplifying assumptions. We dichotomized the miR-223 expression at the
empirical median so that A = 1 if the expression was above the median, or 0 otherwise. We
used a dichotomous indicator of whether death from GBM had occurred in the first three
months as the outcome (Y ). Among the 490 patients, 44 died within the first three months
(Y = 1). We assumed that the patients lost to follow-up prior to three months (four in
the A = 0 group, and five in the A = 1 group) were alive (Y = 0). We assumed that the
baseline demographic variables in the publicly available data (age at diagnosis, gender, and
ethnicity), which we jointly denoted by L, were sufficient for the identifying assumptions
(8)–(10) to hold. In practice, a richer set of (baseline) covariates should be adjusted for in
substantive analyses to reduce the possibility of biases due to unobserved confounding.
The proposed estimation strategy for high-dimensional mediators described in Section 3.2
was carried out. For the purposes of selecting confounders, linear models were assumed for
all (continuous) mediators, and a logistic regression model was assumed for the (binary)
outcome. The penalized regression models using elastic net penalties were fitted using the
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glmnet package (Friedman et al., 2010) in R. The value of the tuning parameter that
controlled the overall strength of the penalty in each model was selected using 10-fold
cross-validation (the default setting) on either the mean squared error (for the continuous
mediators) or the misclassification error (for the binary outcome). We again emphasize
that the mediator models were used merely to select possible confounders of the mediator-
outcome relations that required adjustment (in the subsequent unpenalized outcome model)
to avoid biases due to unobserved confounding. Estimating each indirect effect only requires
an outcome model fitted to the observed data, and does not require assuming any model for
the mediators. Because treatment was not randomly assigned, counterfactual mediator values
were sampled using the proposed weights in Section 3.3 under a saturated logistic regression
model for treatment conditional on the baseline covariates. For each mediator, we plotted
the (penalized) estimated regression coefficients of treatment in the linear mediator model,
and of the mediator in the logistic outcome model, in Figure 2. Each panel corresponded to
one of the nine (overlapping) sets of mediators defined in Table 2 of Huang and Pan (2016).
We refer readers to Huang and Pan for details of the biological functions of each gene set.
[Figure 2 about here.]
Non-parametric bias-corrected and accelerated 95% confidence intervals (CIs) were con-
structed, by applying the bca function (Kropko and Harden, 2020) to 500 bootstrap samples
that randomly resampled observations with replacement and repeated the estimation pro-
cedure for each sample. Genes whose 95% CIs excluded zero are displayed in Table 3. The
interventional indirect effect via an individual gene can be interpreted using the following
example. The odds of death from GBM within three months due to shifting the marginal
distribution of the PIK3CD gene expression from those with observed miR-223 expressions
above the median to those below the median, while holding the distributions of all other gene
expressions fixed among those with miR-223 expressions below the median, was estimated to
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increase by exp(0.62) ≈ 1.85 times (95% CI = (1.20, 2.61)). To compare our results with those
in Huang and Pan, we indicated in Table 3 which gene set(s) each distinct gene belonged
to. Huang and Pan found that all nine gene sets significantly mediated the causal effect of
miR-223 expression on GBM mortality within three months (with p-values less than 0.05).
We (similarly) found that each gene set contained at least one gene with a (significantly)
non-zero interventional indirect effect. Because several simplifying assumptions were made
for the sole purpose of illustrating the proposed estimation strategy, substantive conclusions
about the biological significance of the statistically significant mediators are beyond the
scope of this article.
[Table 3 about here.]
6. Comparison
In this section, we argue that in common settings, the interventional effects proposed in
this article are equal to existing definitions by Vansteelandt and Daniel (2017). In partic-
ular, the existing definitions rely on (counterfactual) mediator distributions that depend
on treatment and all baseline covariates, including confounders of the mediator(s)-outcome
relation(s). Suppose that all mediators are continuous, so that linear mean models for the
mediators (conditional on L) may be assumed. Suppose that the outcome is dichotomous,
and sufficiently rare so that the logit link in a (marginal structural) mean model for the
outcome can be approximated by the log link. When (i) the outcome model has main effects
only, and (ii) the effect of treatment on the mediators is not moderated by the confounders
(i.e., there are no interaction terms involving treatment in the mediator mean models), the
proposed interventional effects are equal to existing definitions. Detailed results are provided
in Web Appendix ??.
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7. Conclusion
In this article, we have developed interventional effects for high-dimensional mediators that
permit a novel estimation strategy allowing for any (marginal structural) mean model for the
outcome, and requiring no models for the mediators. There are several avenues of possible
future related research. The proposed estimation strategy for high-dimensional mediators
is designed to deliver reasonable approximations of the indirect effects through selecting
confounders (including other mediators) using the double selection principle. Establishing
theoretical properties to ensure valid inference of the proposed Monte Carlo-based estimators,
especially following mediator selection, is an area of future work. When selecting a subset of
the mediators for further investigation, a threshold that either is pre-determined, such as in
Huang and Pan (2016), or controls the familywise error rate under multiple testing scenarios,
such as in Derkach et al. (2020), can be used. When further interest is in estimating the
direct, joint, or mutual indirect effects, a separate penalized regression model for the outcome
(conditional on all the mediators, covariates, and treatment) must be fitted to the observed
data for predicting the potential outcomes in Table 1, and in the first and last rows of Table 2,
of the estimation strategy in Section 3.1. The estimated interventional indirect effects via
each distinct mediator can be used to determine the penalties; e.g., the indirect effects can be
used in place of the product of coefficients in the penalties for the pathway lasso (Zhao and
Luo, 2016). High-dimensional mediation methods that employ principal components analysis,
such as Huang and Pan (2016) and Zhao et al. (2020), can be used to select mediators with
high loadings in the principal components. Substantive comparisons of the indirect effects
through specific selected (sets of) mediators using such approaches, with the interventional
indirect effects developed in this article, may be made in future work. Unbiased estimation
of the interventional effects defined in this article depends on correctly specifying a mean
model for the outcome. Vansteelandt et al. (2012) recommend using sufficiently rich outcome
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models that e.g., include higher-order or interaction terms between treatment and mediators,
or between mediators. Assessing robustness to misspecification of the outcome model, e.g.,
due to omitting such interaction terms, is a direction for future research. Other more general
non-parametric prediction methods for the potential outcomes that leverage data-adaptive
techniques (Dı´az et al., 2019; Benkeser, 2020) can also be considered. Extending such machine
learning methods to high-dimensional settings requires further work to avoid the need for
inverse weighting by the joint mediator density.
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Figure 1. Causal diagram for an example with three mediators, two of which share an
unobserved confounder U . Observed variables are drawn as rectangular nodes and unobserved
variables are drawn as round nodes.
A M1 U M2 M3 Y
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Figure 2. Scatterplots of the (penalized) regression coefficients in the linear mediator
and logistic outcome models for the GBM data set. Each point corresponds to a distinct
mediator, with the coefficient of treatment on the mediator in question on the vertical axis
(“A → M”), and the coefficient of the mediator on the outcome on the horizontal axis
(“M → Y ”). The size and color of the points are proportional to the (absolute) magnitudes
of the indirect effects, with larger points and darker (red) hues indicating indirect effect
estimates further from zero. Mediators whose 95% CIs excluded zero are circled in black.
Each panel corresponds to one of the nine sets of mediators described in Huang and Pan.
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Table 1
Duplicated data for each individual when estimating the direct and joint indirect effects. The counterfactual
mediators {M˜1a(1) · · · M˜pa(1)} are randomly drawn (jointly) from the observed treatment group A = a(1). The column
L is omitted for simplicity.
a(0) a(1) {M˜1a(1) · · · M˜pa(1)} E
(
Ya(0)M˜
1a(1)
···M˜
pa(1)
|L
)
0 0 {M˜10 · · · M˜p0} hˆ(0, M˜10, . . . , M˜p0, L)
0 1 {M˜11 · · · M˜p1} hˆ(0, M˜11, . . . , M˜p1, L)
1 1 {M˜11 · · · M˜p1} hˆ(1, M˜11, . . . , M˜p1, L)
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Table 2
Duplicated data for each individual when estimating the separate indirect effects via each mediator. There are t + 2
rows for a binary treatment A. The counterfactual mediators M˜sa(s) are randomly drawn from the observed
treatment group A = a(s), s = 1, . . . , p. The column L is omitted for simplicity.
a(0) a(1) a(2) · · · a(p−1) a(p) M˜1a(1) M˜2a(2) · · · M˜p−1,a(p−1) M˜pa(p) E
(
Ya(0)M˜
1a(1)
···M˜
pa(p)
|L
)
0 0 0 · · · 0 0 M˜10 M˜20 · · · M˜p−1,0 M˜p0 hˆ(0, M˜10, . . . , M˜p0, L)
0 1 0 · · · 0 0 M˜11 M˜20 · · · M˜p−1,0 M˜p0 hˆ(0, M˜11, . . . , M˜p0, L)
0 0 1 · · · 0 0 M˜10 M˜21 · · · M˜p−1,0 M˜p0 hˆ(0, M˜10, . . . , M˜p0, L)
...
...
...
...
...
...
...
...
...
...
...
...
0 0 0 · · · 1 0 M˜10 M˜20 · · · M˜p−1,1 M˜p0 hˆ(0, M˜10, . . . , M˜p0, L)
0 0 0 · · · 0 1 M˜10 M˜20 · · · M˜p−1,0 M˜p1 hˆ(0, M˜10, . . . , M˜p1, L)
0 1 1 · · · 1 1 M˜11 M˜21 · · · M˜p−1,1 M˜p1 hˆ(0, M˜11, . . . , M˜p1, L)
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Table 3
Estimates (“Est.”) on the log-odds scale, and non-parametric bias-corrected and accelerated bootstrap 95%
confidence intervals (“CIs”), for the interventional indirect effects via each distinct gene in the GBM data set. Only
genes whose 95% CIs excluded zero are displayed. The genes are ordered by increasing lower bound of their 95% CI.
Each gene either belongs (“X”) or does not belong (“–”) to a gene set described in Huang and Pan. The gene sets in
the column headings are labelled as (i) GO0009607, (ii) GO0051707, (iii) GO0016064, (iv) GO0019724, (v)
GO0045088, (vi) GO0002443, (vii) GO0002285, (viii) GO0002764, and (ix) GO0006952. All results are rounded to
two decimal places.
Gene Est. 95% CI (i) (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix)
FYB -0.44 -1.16 -0.28 – – – – – – – X –
TMEM173 -0.37 -0.99 -0.07 X X – – X – – – X
PRDM1 -0.14 -0.82 -0.15 X X – – – – – – –
SAA1 -0.09 -0.71 -0.08 – – – – – – – – X
SAA2 -0.10 -0.69 -0.09 – – – – – – – – X
FCN2 -0.33 -0.66 -0.16 – – – – – – – – X
IRF5 -0.24 -0.62 -0.09 X X – – – – – – X
ARRB2 -0.22 -0.58 -0.08 – – – – X X – X X
SPON2 -0.11 -0.55 -0.03 – – – – – – – – X
NUPR1 -0.04 -0.54 -0.01 – – – – – – – – X
SAA4 -0.35 -0.48 -0.05 – – – – – – – – X
CD226 -0.22 -0.48 -0.10 X – X X X X – X X
NCAM1 -0.18 -0.48 -0.03 – – – – – – – – X
UACA -0.12 -0.43 -0.02 – – – – – – – – X
CYP11A1 -0.10 -0.39 -0.01 X X – – – – – – –
FOS -0.06 -0.38 -0.00 X X – – X – – X X
GUCY1A3 -0.05 -0.31 -0.00 X X – – – – – – –
LGALS8 0.25 0.00 0.57 – – – – – – X – –
TXN 0.10 0.00 0.34 – – – – – – – – X
CCDC130 0.13 0.00 0.36 X X – – – – – – –
DEFA5 0.11 0.00 0.44 X X – – – – – – X
APOBEC3G 0.18 0.01 0.63 X X – – – – – – X
IL17RA 0.13 0.01 0.59 – – – – – – – – X
CCL4 0.15 0.03 0.47 X X – – – – – – X
TCF3 0.14 0.03 0.51 X X – – – – – – –
LSP1 0.24 0.04 0.67 – – – – – – – – X
CFH 0.11 0.04 0.50 – – – – – – – – X
TAPBP 0.09 0.04 0.60 – – – – – – – – X
CTSB 0.25 0.05 0.91 – – – – – – – – X
FZD5 0.12 0.05 0.40 X X – – – – – – –
TSPO 0.19 0.05 0.63 X X – – – – – – –
SPHK1 0.20 0.06 0.56 – – – – – – – – X
GBP3 0.21 0.12 0.52 X X – – – – – – X
IRF1 0.18 0.13 0.61 X X – – X – – X X
A2M 0.29 0.14 0.75 – – – – X – – – X
PIK3CD 0.62 0.18 0.96 – – – – – X – X X
CLEC5A 0.39 0.25 0.82 X X – – – – – – X
ITK 0.43 0.25 0.85 – – – – – – – X X
